At the completion of this CME teaching activity, you should be able to:
- Discuss the most common diagnostic pitfalls in a diagnosis of well-differentiated lipomatous tumors
- Discuss the most common diagnostic entities in the differential diagnosis of myxoid, spindle cell, pleomorphic and round cell tumors
- Understand how to integrate clinical history, laboratory data, and imaging findings to come to a uniform diagnosis when presented with an unexpected histologic feature in a liver biopsy
- Recognize the liver tumors that can closely resemble hepatocellular carcinoma and the proper immunostain panel to identify that
- Identify the histologic features that allow for the diagnosis of Wilson disease, hereditary hemochromatosis, and alpha-1 antitrypsin deficiency
- Summarize the morphologic and molecular features of special histologic subtypes of triple negative breast cancer and management implications
- Review recent updates on biomarker testing in breast cancer
- Discuss diagnostic challenges in breast core needle biopsies and how to resolve these issues on difficult cases
- Describe the various histologic patterns of colitis and their differential diagnoses
- Recognize the key factors that predict prognosis and guide therapeutic decision making in colorectal cancer
- Classify appendiceal tumors according to updated criteria to guide subsequent therapy and predict prognosis
- To highlight common controversial topics in prostate pathology with a focus on grading and reporting parameters
- To review diagnostic challenges encountered in common bladder specimens
- To emphasize a practical approach to common diagnostic challenges in kidney tumors
- Discuss the most useful histologic and immunohistochemical findings in diagnosing serious neoplasms of the uterus and ovary, including a focus on HER2 testing
- Discuss some of the most common entities in cervical pathology seen in post-menopausal patients
Program ;
Well-Differentiated Fatty Tumors: Common Diagnostic Issues
John R. Goldblum, M.D.
Uterine Serous Carcinoma and HER-2 Testing
Natalie Banet, M.D.
The Unexpected Liver Biopsy Finding: What To Do When Things Don't Add Up
John Hart, M.D.
Differential diagnosis of Inflammatory Bowel Disease
Rish K. Pai, M.D., Ph.D.
Breast Core Needle Biopsies: Pitfalls and Pearls
Hannah Yong Wen, M.D., Ph.D.
Controversies in Prostate
Jane Nguyen, M.D., Ph.D.
Cervical Pathology in Post-Menopausal Patients
Natalie Banet, M.D.
Mimics of Hepatocellular Carcinoma: How to Get the Right Diagnosis
John Hart, M.D.
Update on Colorectal Cancer Reporting
Rish K. Pai, M.D., Ph.D.
Pattern-Based Approach to Soft Tissue Tumors
John R. Goldblum, M.D.
The Spectrum of Triple Negative Breast Cancer
Hannah Yong Wen, M.D., Ph.D.
Diagnostic Challenges in Bladder
Jane Nguyen, M.D., Ph.D.
Ovarian Serous Neoplasms: Diagnostic Updates and New Therapeutics
Natalie Banet, M.D.
Practical Considerations in Kidney Tumors
Jane Nguyen, M.D., Ph.D.
Practical Approach to Appendiceal Tumors
Rish K. Pai, M.D., Ph.D.
Prognostic and Predictive Markers in Breast Cancer
Hannah Yong Wen, M.D., Ph.D.
Why Am I Routinely Doing Those Special Stains on Liver Biopsies? The Ins and Outs of Hereditary Metabolic Liver Diseases
John Hart, M.D.